Wilbur Lam, professor at Georgia Tech and Emory University, and a clinician at Children’s Healthcare of Atlanta, led the study. He worked closely with Yongzhi Qiu, an assistant professor in the Department of Pediatrics at Emory University School of Medicine. 

The significance of the thromboinflammation-on-a-chip model, is that it mimics clots in a human-like way, allowing them to last for months and resolve naturally. This model helps track blood clots and more effectively test treatments for conditions including sickle cell anemia, strokes, and heart attacks. 

Read the full story from Emory University